Patent · US Active

Compounds

US8178583B2 · kind B2 · utility

0Cited by

3References

20Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Torsten Hoffmann · Weil am Rhein, DE
Holger Kuehne · Soest, DE
Eric Niesor · Gland, CH
Philippe Pflieger · Schwoben, FR

Key dates

Filing date	Dec 7, 2009
Grant date	May 15, 2012
Priority date	—
Expiry date	Mar 9, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with compounds of formula I:wherein R, R2, and Q are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are useful as inhibitors of cholesteryl ester transfer protein (CETP).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.